Sorted by last column: close/minimum low past 250 days. Note next earnings dates.
All Posts
Blog Post: Day 20 of $QQQ short term up-trend; 18 stocks on my IBD/MS growth stock list reached an ATH on Friday, see list
These stocks are sorted according to current price divided by lowest price the past 250 days. Seven are 2x or more their lowest price the past year. Doublers are worth studying to see if they meet one’s set-up for a low risk purchase. Be sure to note the next earnings report date for each, in column 3. The greatest winning stocks break out to an ATH and then go on to a series of ATHs over many months. Why buy the fallen angels when there are some new ones rocketing to historic heights?
The GMI remains Green. So many people are chasing income instead of growth stocks these days. The crowd is usually wrong and will get back into stocks long after the market has advanced. I noticed for many years that the media proclaimed a bull market about 6 months after the bear market bottom was in.
Blog Post: Day 19 of $QQQ short term up-trend; 19 stocks on my IBD/MS watch list at ATHs on Thursday, see list which includes $LLY and $NVO
This list is sorted by the close Thursday divided by lowest price the past 250 days. Four have doubled their low price. Note also the next earnings dates and that NVO and LLY hit ATHs today. News from the FDA about their drugs for obesity is due this month. True market leaders show up on ATH lists.
